Eosinophilic granulomatosis with polyangiitis: Which Medications Cause It? (1,786 Reports Across 185 Drugs)
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Eosinophilic granulomatosis with polyangiitis has been reported as an adverse event with 185 different drugs in the FDA's FAERS database, with 1,786 total reports. 104 of these reports resulted in death.The drugs most commonly associated with Eosinophilic granulomatosis with polyangiitis are MONTELUKAST, MEPOLIZUMAB, and PREDNISONE.
1,786
Total Reports
185
Drugs Involved
104
Deaths
819
Hospitalizations
56.1 yrs
Average Patient Age
47.2% / 52.8%
Female / Male
Which Drugs Cause Eosinophilic granulomatosis with polyangiitis Most Often?
| Drug | Reports | % of Drug Reports | Deaths | Hosp. | Life-Threat. |
|---|---|---|---|---|---|
| MONTELUKAST | 504 | 1.9% | 60 | 312 | 153 |
| MEPOLIZUMAB | 499 | 1.2% | 68 | 204 | 148 |
| PREDNISONE | 478 | 0.3% | 53 | 234 | 170 |
| ALBUTEROL | 477 | 0.5% | 60 | 250 | 162 |
| FLUTICASONE\SALMETEROL | 283 | 0.6% | 54 | 193 | 115 |
| DUPILUMAB | 275 | 0.1% | 3 | 95 | 15 |
| BUDESONIDE | 257 | 1.0% | 58 | 130 | 163 |